BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by ...

Global Transcriptomics Market size is expected to be worth around US$ 23.6 Billion by 2034 from US$ 7.4 Billion in 2024.

I will start with the conclusion. As of today, there are 89 days left until the Rheumatology Specialist Exam (January 17, ...

The DNA inside our cells isn’t just a series of instructions, but something far more dynamic. Like scientists, AI models ...

A new review argues that AI-driven antiviral discovery must be benchmarked against respiratory RNA virus polymerases under ...

A new mouse study shows that hypoxic culture enhances zygotic genome activation by increasing H3K4me3 at zygotic gene ...

Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.

A global mapping project revealed tens of thousands of previously unknown viruses circulating in environments with high human traffic, such as transit ...

Spread the loveImagine a world where detecting deadly viruses like HIV, influenza, or even the next emergent pathogen isn’t a ...

Ambry Genetics, a leader in clinical genomic testing and a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM), today announced the launch of GenomeNext™ and GenomeReveal™, a comprehensive whole ...

Oxford biotech secures $47 million to scale cell-based mRNA manufacturing, with an eye on therapies that require repeated ...

A research team has identified YYH-6, a newly synthesized pyrimidine–guanidine derivative, as a promising antiviral candidate ...